New carbapenemase inhibitors: clearing the way for the β-lactams

JC Vázquez-Ucha, J Arca-Suárez, G Bou… - International journal of …, 2020 - mdpi.com
Carbapenem resistance is a major global health problem that seriously compromises the
treatment of infections caused by nosocomial pathogens. Resistance to carbapenems …

β-lactam antibiotics and β-lactamase enzymes inhibitors, part 2: our limited resources

S Alfei, AM Schito - Pharmaceuticals, 2022 - mdpi.com
β-lactam antibiotics (BLAs) are crucial molecules among antibacterial drugs, but the
increasing emergence of resistance to them, developed by bacteria producing β-lactamase …

[HTML][HTML] The development of New Delhi metallo-β-lactamase-1 inhibitors since 2018

X Gu, M Zheng, L Chen, H Li - Microbiological Research, 2022 - Elsevier
New Delhi metallo-β-lactamase-1 (NDM-1) can hydrolyze almost all antibiotics of the β-
lactam group, resulting in the generation of multidrug resistant bacteria. Besides its broad …

Repurposing FDA approved drug molecules against ABC classes of β-lactamases: a computational biology and molecular dynamics simulations study

N Farhat, AU Khan - Journal of Biomolecular Structure and …, 2023 - Taylor & Francis
Abstract β-lactamase are the main resistance factor for β-lactam antibiotics in Gram-negative
bacteria. Since β-lactam antibiotics are being utilised as an antimicrobial agents extensively …

Dithiocarbamates combined with copper for revitalizing meropenem efficacy against NDM-1-producing Carbapenem-resistant Enterobacteriaceae

C Chen, KW Yang, L Zhai, HH Ding, JZ Chigan - Bioorganic Chemistry, 2022 - Elsevier
The worldwide prevalence of NDM-1-producing Gram-negative pathogens has drastically
undermined the clinical efficacy of carbapenems, prompting a need to devise an effective …

Novel Antimicrobial Peptide SAAP Mutant as a Better Adjuvant to Sulbactam-Based Treatments Against Clinical Strains of XDR Acinetobacter baumannii

A Naha, S Ramaiah - Probiotics and Antimicrobial Proteins, 2024 - Springer
The production of extended spectrum β-lactamases (ESBLs) in extensively drug-resistant
(XDR) strains of Acinetobacter baumannii has created havoc amongst clinicians making the …

Bacterial biopolymers in tissue engineering and regenerative medicine; current applications and future perspective

B Bakhshandeh, F Mohammadipanah… - Biocatalysis and …, 2023 - Elsevier
Tissue engineering (TE), a fast-growing field of regenerative medicine, has been designed
to replace diseased or damaged tissues. As cellular factories, microbes produce a wide …

Phenotypic and in silico studies for a series of synthetic thiosemicarbazones as New Delhi metallo-beta-lactamase carbapenemase inhibitors

JS Moreira, DS Galvão, CFC Xavier… - Journal of …, 2022 - Taylor & Francis
The past two decades have been marked by a global spread of bacterial resistance to β-
lactam drugs and carbapenems derivatives are the ultimate treatment against multidrug …

Inhibitory potential of polyclonal camel antibodies against new Delhi Metallo-β-lactamase-1 (NDM-1)

R Ben Abderrazek, S Chammam, A Ksouri, M Perilli… - Molecules, 2020 - mdpi.com
New Delhi Metallo-β-lactamase-1 (NDM-1) is the most prevalent type of metallo-β-
lactamase, able to hydrolyze almost all antibiotics of the β-lactam group, leading to multidrug …

同时产碳青霉烯酶NDM-1 和NDM-5 的猪源大肠埃希氏菌的鉴定及耐药性研究

李海利, 郎利敏, 张青娴, 游一, 朱文豪, 王治方… - 生物技术 …, 2022 - biotech.aiijournal.com
为了解携带碳青霉烯酶NDM-1 及其亚型在猪场的流行情况, 对来自猪场产房仔猪腹泻病例分离
鉴定的87 株大肠杆菌进行了碳青霉烯酶NDM-1 和NDM-5 的耐药基因扩增及测序. 从87 …